PRELIMINARY EVIDENCE OF A MOLECULAR PREDICTOR OF TAZEMETOSTAT RESPONSE, BEYOND EZH2 MUTATION, IN NHL PATIENTS VIA CHARACTERIZATION OF ARCHIVE TUMOR AND CIRCULATING TUMOR DNA
Blakemore, S.J., Daigle, S.R., McDonald, A.A., Morschhauser, F., Ribrag, V., Salles, G., McKay, P., Tilly, H., Schmitt, A., Le Gouill, S., Fruchart, C., Radford, J., Zinzani, P.L., Assouline, S., CartVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_14
Date:
June, 2017
File:
PDF, 90 KB
english, 2017